Biohaven Ltd. — Director's Dealing 2026

Jan 8, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Biohaven Ltd. (BHVN)
CIK: 0001935979
Period of Report: 2026-01-05

Reporting Person: Buten Matthew (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-05	Common Shares	M	4250	—	Acquired	198246	Direct
2026-01-05	Common Shares	F	2594	$9.93	Disposed	195652	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-01-05	Restricted Share Unit Award	$	M	4250	Disposed		Common Shares (4250)	Direct

Footnotes

F1: This balance includes 544 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2025.

F2: No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.

F3: Each restricted share unit represents the contingent right to receive one common share of the Issuer.

F4: The reporting person was granted 17,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date.

F5: Not applicable.